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Abstract
Fluorescence labeling of bacterial pathogens has a broad range of interesting applications including the observation of
living bacteria within host cells. We constructed a novel vector based on the E. coli streptococcal shuttle plasmid pAT28 that
can propagate in numerous bacterial species from different genera. The plasmid harbors a promoterless copy of the green
fluorescent variant gene egfp under the control of the CAMP-factor gene (cfb) promoter of Streptococcus agalactiae and was
designated pBSU101. Upon transfer of the plasmid into streptococci, the bacteria show a distinct and easily detectable
fluorescence using a standard fluorescence microscope and quantification by FACS-analysis demonstrated values that were
10–50 times increased over the respective controls. To assess the suitability of the construct for high efficiency fluorescence
labeling in different gram-positive pathogens, numerous species were transformed. We successfully labeled Streptococcus
pyogenes, Streptococcus agalactiae, Streptococcus dysgalactiae subsp. equisimilis, Enterococcus faecalis, Enterococcus faecium,
Streptococcus mutans, Streptococcus anginosus and Staphylococcus aureus strains utilizing the EGFP reporter plasmid
pBSU101. In all of these species the presence of the cfb promoter construct resulted in high-level EGFP expression that
could be further increased by growing the streptococcal and enterococcal cultures under high oxygen conditions through
continuous aeration.
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Introduction
Green fluorescent protein (GFP) of the jellyfish Aequorea victoria is
an excellent fluorescent marker since it can be expressed in
heterologous hosts without the need for cofactors or specific
substrates. It shines bright green if activated by blue or UV light
[1][2]. Successful expression of GFP activity has been shown for
numerous organisms ranging from bacteria to mammalian cells of
diverse tissue types [3][4][5][6]. EGFP (enhanced green fluores-
cent protein), is a GFP variant causing a greatly increased
fluorescence intensity compared to the GFP wildtype protein [7].
In contrast to wildtype GFP, which to some extend is found
inactive in inclusion bodies, the solubility of EGFP is considerably
enhanced [7]. GFP variants are very stable molecules [8][9] and
can be used without providing evidence of harmful effects on living
cells [10][11] [1]. Highest fluorescence values are observed in well
oxygenated cultures of a pH-value of 7. The chromophore is
activated at high oxygen conditions [12]. In alkaline as well as
acidic conditions, the fluorescence intensity is noticeably reduced
[13][14].
Successful expression of GFP in different lactic acid bacteria has
been reported from several laboratories [15][16] [13]. The ability
of streptococcal strains expressing GFP to survive in vivo and to be
suitable for pathogenesis studies has been demonstrated for
Streptococcus suis [15]. Streptococci are lactic acid bacteria that
comprise numerous facultative pathogenic species and several
highly virulent bacterial pathogens, like S. pyogenes. They are
facultative anaerobes that grow well under low oxygen conditions
often requiring 5% CO2 for optimal growth. Together with an
increased tolerance for low pH values these physiological features
are in contrast to the conditions under which optimal GFP
expression is observed. These facts may explain why the majority
of GFP- constructs in streptococci so far resulted in measurable but
moderate fluorescence values [17][18] that could not match the
levels of expression observed in gram-negative bacteria like E. coli.
In the present study, a vector construct that was derived from
plasmid pAT28 [19] and contains a promoterless copy of the egfp
gene downstream of its multiple cloning site was studied. In the
specific construct the expression of EGFP is driven the promoter of
the CAMP-factor gene of S. agalactiae. The CAMP-factor is a cell
surface associated molecule that is responsible for the cohemolysis
of erythrocytes in the presence of S. aureus and independent from
the S. agalactiae ß-hemolysin. This phenomenon is often used for
diagnostic purposes in the species identification of S. agalactiae. The
identification of the gene cfb, encoding the CAMP-factor, was
published several years ago and includes the description of the
promoter region [20]. The CAMP-factor has been shown to
represent a pore forming toxin in S. agalactiae [21]. A gene similar
to cfb is present in S. pyogenes [22] (designated cfa), indicating that
the function of the cfb promoter may not be limited to S. agalactiae.
To assess the potential role of the plasmid as a general tool to
provide EGFP-labeling, the construct was investigated for its
ability to enable high-level EGFP expression in numerous gram-
positive hosts.
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Bacterial strains, cell line and growth conditions
The bacterial strains and plasmids used in this study are listed in
Table 1. Gram positive bacteria weregrown at 37uC in THY (Todd
Hewitt Broth (Oxoid, Wesel, Germany)) supplemented with 0.5%
yeast extract) containing 120 mg/l spectinomycin. The monocytic
cell line THP-1 (ATCC, East Greenwich, RI, USA) was grown at a
density of 3610
5 cells/ml at 37uC in a humidified atmosphere
containing 5% CO2 in complete medium (RPMI 1640 medium
(Sigma, Deisenhofen, Germany), supplemented with 10% heat
inactivated FCS, 50 mM 2-Mercaptoethanol, 2 mM L-glutamine,
10 mMHepes,100 mg/ml penicillin and160 mg/mlgentamicin,all
Seromed-Biochrom (Berlin, Germany). Cells were passaged every
72 h. In order to differentiate THP-1 cells into macrophages, cells
were cultured for 24 h at 37uC and 5% CO2 in complete medium
supplemented with 10 ng/ml Phorbol 12-myristate 13-acetate
(PMA, Sigma, Deisenhofen, Germany)
Construction of the reporter plasmid pBSU101
The plasmids pBSU101 and pBSU100 were constructed in E. coli
DH5a. Both plasmids are derivatives of pAT28. A promoterless
copy of the egfp gene was inserted into pAT28 via the XbaI
restriction sites flanking this gene in the vector pEGFP (BD
Biosciences,SanJose,CA),whichservedasa source foregfp.Correct
insertionofegfpinthisconstructwasconfirmed byDNAsequencing.
The resulting plasmid was designated pBSU100 and served as
control vector for subsequent experiments. To control expression of
EGFP in pBSU101 the promoter region of the Streptococcus agalactiae
gene cfb was inserted into pBSU100. The promoterregion including
the ATG startcodon of cfb was amplified by PCR using the primers
cfbProm1 and cfbProm2 (Table 2) which add EcoRI and BamHI
restriction sites to the cfb promoter. Following digestion of the PCR
product and the pBSU100 vector with BamHI and EcoRI, plasmid
and insert were ligated applying standard molecular biology
techniques. Selection was carried out on LB (Luria Bertani) agar
plates supplemented with 125 mg/l of spectinomycin. Correct
insertion was confirmed by performing a PCR reaction using
primers PBSU100-for1 and PBSU100-rev1, which are flanking the
multiple cloning site of pBSU100 (see Table 2) and subsequent
sequencing of the PCR product. The insertion of the fragment into
pBSU100 resulted in a translational fusion of the first 7 amino acids
of CFB to the N-terminus of EGFP as depicted in Fig. 1.
Plasmid transformation
Transformation of the different bacterial strains was achieved
by electroporation. For transformation of enterococcal and
streptococcal strains the protocols of Friesenegger, et al. [23] and
Ricci et al. were used [24]. The method relies on the generation of
electrocompetent cells through repeated washes in 10% glycerol.
For S. aureus the transformation was conducted as described in [25]
using the restriction deficient strain RN4220 [26]. Recombinant
streptococcal and enterococcal strains were selected on THB
(Todd Hewitt broth) or blood agar plates supplemented with
120 mg/l spectinomycin.
FACS analysis of EGFP expressing bacterial strains
Streptococal, enterococcal strains and S. aureus were grown
overnight in THY broth at 5%CO2 or in THY broth under
continuous shaking. Bacteria were harvested by centrifugation,
washed once and resuspended in PBS (phosphate buffered saline,
pH 7.4). Quantification of fluorescence was achieved by FACS
analysis (FACSCaliburH, Becton Dickinson Immunocytometry
Systems, San Jose, CA) using the following instrument settings:
FSC: E00, SSC: 400, FL-1: 700. Relative fluorescence values were
determined by analyzing 10 000 events for each sample.
THP-1 experiments
Bacterial strains were grown overnight on 5% sheep blood agar
plates supplemented by 125 mg/l of spectinomycin. Bacteria were
resuspended in prewarmed RPMI (Sigma, Deisenhofen, Germany)
without supplements, to a density of 10
7 bacteria/ ml. 2610
5
THP-1 cells were incubated with the S. agalactiae strains at a
multiplicity of infection of 1, 10, and 100 and kept for one hour in
complete medium supplemented with 5% human plasma
(Biochrom, Berlin, Germany) at 37uC and 5% CO2. Microscopy
of THP-1 cells was performed with a Zeiss Axioskop-2H
Table 1. Bacterial strains and plasmids.
Strains Description Source or reference
E. faecalis BSU 386 Clinical isolate Ulm collection
E. faecium BSU 385 Clinical isolate Ulm collection
S. anginosus BSU 458 ATCC 12395 American Type Culture Collection
S. mutans BSU 269 DSM 20523 DSMZ collection
S. pyogenes BSU 317 clinical isolate Ulm collection
S.agalactiae BSU6 serotype Ia strain clinical isolate Ulm collection
S. dysgalactiae subsp. equisimilis group C BSU 225 Clinical isolate Ulm collection
S. dysgalactiae subsp. equisimilis group G BSU 263 AC 1140 Aachen collection
Staphylococcus aureus BSU 542 RN 4220 Kreiswirth et al., 1983
Escherichia coli DH5a endA1 hsdR17 supE44 DlacU169 (w80lacZDM15) recA1 gyrA96 thi-1 relA1 Boehringer Ingelheim
Plasmids
pAT28 Spec
r ori pUC ori pAmb1 Trieu-Cuot et al., 1990
pEGFP Am
r, source of egfp Clontech Laboratories
pBSU100 pAT28 derivative carrying egfp this study
pBSU101 pAT28 derivative carrying egfp under the control of the cfb promoter this study
doi:10.1371/journal.pone.0019822.t001
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Axiovison software version 4.6. For quantification samples were
analyzed using a FACSCaliburH with CellQuest-ProH software
(Becton Dickinson, San Diego, CA).
Results
Establishment of the EGFP-construct in different
streptococci and related genera
The reporter construct used in the present study is a derivative
of the pAT28 plasmid [19]. This plasmid is a streptococcal E. coli
shuttle vector present in multiple copies in the cytoplasm of
transformed strains. A promoterless copy of egfp was integrated
into pAT28 and expression of EGFP in this vector is driven by the
promoter region of cfb, the CAMP-factor gene of S. agalactiae
(Fig. 1). A translational fusion of the first seven amino acids of CFB
to the N-terminal region of EGFP was created for optimal
expression of EGFP. The construct was designated pBSU101 and
resulted in brightly fluorescent S. agalactiae cells (Fig. 2), while
control strains carrying the construct without promoter
(pBSU100), did not reveal elevated fluorescence (Fig. 2, Fig. 3).
To evaluate, if a similar expression of EGFP is achieved in other
gram-positive hosts, pBSU101 was transformed successfully in
numerous bacterial pathogens. Numerous streptococcal species
including highly pathogenic ß-hemolytic strains (S. pyogenes, S.
dysgalactiae subsp. equisimilis, and S. agalactiae) as well as viridans
streptococci (S. mutans, S. anginosus) were used. To assess expression
in related genera, enterococci (Enterococcus faecalis and Enterococcus
faecium) and Staphylococcus aureus were transformed with the
construct. In every bacterial species and strain that could be
successfully transformed a bright fluorescence was detectable
(Fig. 2). Unfortunately, despite repeated efforts to establish the
vector construct in S. pneumoniae, transformation of this species with
the pAT derived plasmid could not be achieved (Simone
Bergmann, Braunschweig, personal communication), even though
successful labeling of S. pneumoniae by GFP has been described [27].
Level of EGFP-expression
Due to the high fluorescence values that were observed after
transfer of the plasmid, positive clones could easily be detected in a
Figure 1. Depicted is a vector map of shuttle vector pBSU101 that was used in this study to label different gram-positive bacteria
with EGFP. The multiple cloning site (MCS), the different origins of replication (for use in gram-positive hosts, oriR pAMß1, and gram-negative
bacteria, oriR pUC) and the spectinomycin (spc) resistance gene are indicated. The plasmid is a derivative of pAT28. Expression of EGFP in pBSU101 is
controlled via the promoter region of the CAMP-factor gene cfb of Streptococcus agalactiae. The plasmid carries the promoter region and the ATG
startcodon of cfb, resulting in a translational fusion of the first 7 amino acids of CFB to the N-terminus of EGFP as depicted. Between the CFB fragment
and the start of EGFP a small spacer of 8 amino acids is found that does not appear to disturb efficient EGFP expression.
doi:10.1371/journal.pone.0019822.g001
Table 2. Primers used for the construction and analysis of pBSU100, pBSU101.
name sequence target gene
cfb-Prom1 59- AAC GAA TTC ATC TAA AAT AGT ACG C-39 cfb of S. agalactiae
cfb-Prom2 59- CGC GGA TCC ATC ATA TGT TTA ACG-39 cfb of S. agalactiae
PBSU100-for1 59-GTT GTG TGG AAT TGT GAG CGG-39 MCS pBSU100, pBSU101
PBSU100-rev1 59-CCT TGA AGA AGA TGG TGC GC-39 MCS pBSU100, pBSU101
doi:10.1371/journal.pone.0019822.t002
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relative fluorescence in comparison to the negative control strains
was performed by FACS analysis of overnight cultures in THY
broth. In these measurements, an increase of 10 to 50 times over
the baseline values that were observed for the control strains (Fig. 2)
was noted. Typically relative fluorescence values around 1000–
5000 could be measured while the negative control strains are
around 100. Streptococci and enterococci are facultative anaer-
obes and often grow best under low oxygen conditions, which is
not optimal for EGFP-folding. To assess the effect of providing the
cultures with additional oxygen, we compared standard growth
conditions with cultures grown under continuously shaking
conditions. For all of the streptococcal and enterococcal strains,
fluorescence intensity was higher in the agitated samples; increases
between 65 and 125% were observed (Fig. 2). In contrast to these
observations, growing Staphylococcus aureus under continuously
shaking conditions had no effect (Fig. 2). Since EGFP expression
in S. aureus appeared somewhat lower than in most streptococcal or
enterococcal species (Fig. 2) we performed Western blot
experiments with antibodies specific for EGFP to evaluate EGFP
expression in S. aureus. However no indication for a degradation of
EGFP could be observed in the immunoblot (data not shown). To
investigate the level of EGFP expression provided by pBSU101 in
different growth phases, cultures grown to an OD(600 nm) of 0.2,
0.4, 0.6, 0.8, and 1.0 were analyzed by FACS. For these
experiments three different bacterial species (S. agalactiae, S. mutans
and E. faecalis) were selected representing ß-hemolytic streptococci,
viridans streptococci and enterococci. In all of these species high-
level EGFP expression can already be observed in the early
logarithmic growth phase at an OD of 0.2 (Fig. 4).
Plasmid stability
Transformation by pBSU101 typically requires growth of the
labeled bacteria under antibiotic pressure to ensure a stable
propagation of the plasmid. To address the question if the plasmid
is maintained in the absence of antibiotic pressure, bacterial strains
harboring the plasmid were grown to saturation in liquid culture
containing antibiotics, diluted 1:100 in fresh medium and grown
overnight in the presence and absence of spectinomycin
supplementation. In all of the strains fluorescence values well
above the negative controls could be observed, even after
overnight growth without antibiotics. However, as to be expected,
the plasmid was not completely stable in all of the strains. While no
significant differences in the fluorescence values could be observed
for S. agalactiae E. faecalis, E. faecium and S. pyogenes (Fig. 5). A
marked drop of the fluorescence values in the bacterial cultures
lacking antibiotics was seen for S. dysgalactiae subsp. equisimilis
(group C and group G strains), S. mutans, S. anginosus and
Staphylococcus aureus.
Detection of eukaryotic host cells harboring EGFP-
positive streptococci
The suitability of the vector construct to visualize macrophage
uptake of fluorescently labeled bacteria was investigated using the
Figure 2. EGFP expression in different bacterial hosts was determined by FACS analysis. Streptococcal, enterococcal strains and S. aureus
were grown overnight in THY broth as described in Material and Methods. Depicted are the values obtained for the ß-hemolytic species S. agalactiae,
S. pyogenes, S. dysgalactiae subsp. equsimilis (SDSE) serogroup C, SDSE serogroup G, Staphylococcus aureus, the enterococcal species E. faecalis and E.
faecium and the viridans group streptococci S. mutans and S. anginosus. Shown are mean values and standard deviations of five independent
experiments.
doi:10.1371/journal.pone.0019822.g002
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are a model for human macrophages. THP-1 macrophages
carrying the EGFP expressing S. agalactiae strain could easily be
detected after 60 min of co-incubation (Fig. 3D). In addition
infection experiments using macrophages and pBSU101 labeled S.
agalactiae strain demonstrate a dose dependent increase of
fluorescent THP-1 cells as assessed by FACS analysis (Fig. 6).
Discussion
Following the successful construction of an EGFP-plasmid for S.
agalactiae, we were interested to evaluate this plasmid as a general
tool for other streptococcal species and related genera. It was
possible to establish pBSU101 in a large variety of gram-positive
species comprising different streptococci as well as enterococci and
even S. aureus. Since transformation by pAT vectors has already
been described for the genera Bacillus [28] and Listeria [29],
including a pAT vector derivative carrying GFP for use in Listeria
[30], it may very well be possible that the range of potential
bacterial hosts for this plasmid is much broader.
The level of fluorescence that was provided by the integration of
the cfb promoter to control egfp transcription in pBSU101 was
unexpected. We had previously noted that the CAMP-factor gene
of S. agalactiae appears to be well transcribed since visualization of
cfb mRNA in Northern blot experiments required considerable
lower amounts of total RNA than other S. agalactiae genes [31].
This observation is consistent with the finding that unexpected
high levels of EGFP expression for streptococci were observed in
our plasmid construct. The increase of relative fluorescence values
(RFU) from a baseline of around 100 RFU or less to 1000–5000
RFU under the control of the cfb promoter was exceptional, if we
compare it to other streptococcal promoters. In a recent
publication [32] we examined the induction of the streptococcal
C5a peptidase gene (scpB) in a derivative of pBSU100 with a
slightly modified multiple cloning site. In this construct EGFP
expression was controlled by the scpB promoter and generated
under inducing conditions maximal relative fluorescence values of
200–250 RFU; a finding that clearly illustrates the strength of the
cfb promoter. Several years ago a close homologue of the CAMP-
factor, was discovered in S. pyogenes [22], an indication that it may
be possible to use the promoter in other streptococcal species and
related genera. Luckily the cfb promoter did not only work for
many different gram-positive bacteria, but also resulted in
continuous high-level expression of EGFP. We were not able to
isolate any bacterial clones harboring pBSU101 but failing to
demonstrate a strong increase in EGFP-expression. This finding
may indicate that the promoter can also be used as a tool to induce
hyperexpression of other genes in gram-positive hosts. However
despite the strong expression of EGFP under the control of the cfb
promoter, Fluorescence measurements that were obtained in the
Figure 3. Fluorescence microscopy of S. agalactiae strain BSU6 transformed with pBSU101 (A) and pBSU100 as control (B). C:
Histogramm (events versus FLH-1) of a FACS analysis of BSU6 harboring pBSU101 (black area) and pBSU100 (white area) D: THP-1 host cells were
incubated with S. agalactiae strain BSU6 carrying plasmid pBSU101 as described in Materials and Methods for 1 hour and visualized with a Zeiss
Axioskop-2H fluorescence microscope.
doi:10.1371/journal.pone.0019822.g003
EGFP in Gram-Pos. Pathogens
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e19822different bacterial species following transformation by pBSU101
demonstrated a considerable amount of variation (Fig. 2). Values
between 1000 to 5000 RFU were noted. The reason for this
heterogeneity is presently unclear and needs to be addressed in
future investigations. Different copy rates of the plasmid, variations
in the transcription or translation rates, degradation of EGFP in
some species or variations in the activation of the chromophore
may be responsible for the observed differences.
The remarkable high-level expression of EGFP under the control
of the cfb promoter may also explain why the construct is able to
Figure 4. EGFP expression in different growth phases was measured by FACS analysis in S. agalactiae, S. mutans, and E. faecalis. Shown
are relative fluorescence units obtained for bacteria grown to an optical density (OD) of 0.2, 0.4, 0.6 0.8 and 1.0. The values represent mean values and
standard deviations of three independent experiments.
doi:10.1371/journal.pone.0019822.g004
Figure 5. EGFP fluorescence in bacterial strains harboring pBSU101 following overnight growth in the presence (+AB) or absence
(2AB) of antibiotic pressure was determined by FACS analysis. Fluorescence values obtained for each bacterial species following overnight
growth under antibiotic pressure were set to a value of 1. Measurements were carried out for S. agalactiae, S. pyogenes, S. dysgalactiae subsp.
equsimilis (SDSE) serogroup C, SDSE serogroup G, E. faecalis, E. faecium, S. mutans, S. anginosus, and Staphylococcus aureus. Shown are the results of
three independent experiments and standard deviations.
doi:10.1371/journal.pone.0019822.g005
EGFP in Gram-Pos. Pathogens
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present in streptococci. Adequate oxygen levels are needed for GFP
fluorophore formation [12] [33] [13] and constitute a problem
regarding facultative anaerobic bacteria like streptococci and
enterococci. These species often grow much better under decreased
oxygen conditions. The low intracellular oxygen conditions have
long been regarded as the reason why many GFP-constructs, that
were used in streptococci so far, did only generate moderate
fluorescence levels. That the oxygen level does indeed limit EGFP-
expression in streptococci and enterococci is nicely shown by the
substantial increase of fluorescence that was observed under
continuous aeration of the growing cultures (Fig. 2). It has however
to be kept in mind that while this is a very easy method to increase
the fluorescence, it may not represent a truly physiologic condition
for streptococci and may thus impair other bacterial functions.
Fluorescence labeling of bacterial pathogens for the investigation of
microbial host cell interactions has been used for many years. One of
the most commonly used substrates for this purpose is fluorescein
isothiocyanate (FITC), which has also been used for many different
applications in streptococci [34][35]. However, FITC is covalently
linked to bacterial surface proteins that may be important for the host
pathogen interactions under investigation. Not surprisingly it has
been demonstrated that FITC-labeling may affect the viability of
microorganisms, impair the integrity of virulence factors and thus
alter the pathophysiology of bacterial pathogens [11]. Fluorescence
labeling by expression of GFP or its variants appears to be
considerably less disruptive and much better suited for in vivo studies.
One major advantage is that the intensity of the fluorescence label
does not decrease with multiplication of the labeled microorganisms,
r e n d e r i n gi tap e r f e c tt o o lf o rin vitro as well as in vivo investigations. In
our experiments employing THP-1 cells we could already show that
the detection of cell associated streptococci using FACS analysis as
well as microscopic analysis works well. For many investigations of
bacterial host interactions bacteria grown to early mid- or late
logarithmic growth phase are used. Analysis of fluorescence values
conferred by this plasmid in different growth phases shows that the
high-level EGFP expression is already present at the early logarithmic
growth phase of an OD of 0.2 (Fig. 4). A feature that is certainly
interesting for researchers who need to fluorescently label bacteria in
a logarithmic growth phase for their experiments. Since not in all
experimental settings it is possible to maintain antibiotic pressure, we
investigatedthestabilityoftheplasmidfollowingremovalofantibiotic
pressure. As to be expected, plasmid loss does occur under these
conditions. However after 24 hours of overnight growth in the
absence of antibiotic pressure the fluorescence label was still
detectable in all of the species we investigated and fluorescence
readings were well above negative controls. Interestingly though for
some species fluorescence readings of bacteria grown in the presence
and absence of antibiotics were indistinguishable after overnight
growth in liquid culture (Fig. 5). This finding may indicate the
possibility to grow bacteria harboring the plasmid without antibiotic
pressure for some time without loss of the fluorescence label. We
would however advise to check this possibility for every species and
every strain independently. Due to the heterogeneity we observed for
plasmid loss in different species it does not seem possible to predict
plasmid stability in the absence of antibiotics.
Due to the specific features of the plasmid we observed, high-level
fluorescence, EGFP expression in very early logarithmic growth phase,
and moderate plasmid stability despite the removal of antibiotic
pressure, the reporter plasmid we constructed will probably be suitable
for a wide variety of applications. It may be interesting for the
investigation of bacterial invasion mechanisms, subcellular localization,
phagocytosis, biofilm arrangement or intracellular survival. The
usefulness of GFP and its derivatives for some of these applications
has already been demonstrated in streptococci [18] [15] [27]. With our
n o v e lp l a s m i dc o n s t r u c tw eh o p et oa d dt ot h i sk n o w l e d g eb yp r o v i d i n g
an easy to use general tool for many different bacterial species.
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